A detailed history of Centaurus Financial, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Centaurus Financial, Inc. holds 12,649 shares of MRK stock, worth $1.26 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
12,649
Previous 12,878 1.78%
Holding current value
$1.26 Million
Previous $1.59 Million 9.91%
% of portfolio
0.1%
Previous 0.11%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$111.15 - $128.97 $25,453 - $29,534
-229 Reduced 1.78%
12,649 $1.44 Million
Q2 2024

Sep 20, 2024

BUY
$123.8 - $132.96 $22,036 - $23,666
178 Added 1.4%
12,878 $1.59 Million
Q1 2024

May 14, 2024

SELL
$113.24 - $131.95 $26,158 - $30,480
-231 Reduced 1.79%
12,700 $1.68 Million
Q4 2023

Feb 26, 2024

SELL
$100.18 - $109.02 $41,775 - $45,461
-417 Reduced 3.12%
12,931 $1.41 Million
Q3 2023

Nov 13, 2023

SELL
$102.95 - $114.33 $119,010 - $132,165
-1,156 Reduced 7.97%
13,348 $1.37 Million
Q2 2023

Aug 15, 2023

SELL
$108.61 - $118.38 $598,441 - $652,273
-5,510 Reduced 27.53%
14,504 $1.67 Million
Q1 2023

May 17, 2023

BUY
$102.94 - $114.86 $215,350 - $240,287
2,092 Added 11.67%
20,014 $2.13 Million
Q4 2022

Feb 10, 2023

SELL
$87.44 - $112.11 $9,268 - $11,883
-106 Reduced 0.59%
17,922 $1.99 Million
Q3 2022

Dec 05, 2022

BUY
$84.53 - $94.96 $25,020 - $28,108
296 Added 1.67%
18,028 $1.55 Million
Q2 2022

Aug 02, 2022

BUY
$83.49 - $94.64 $186,099 - $210,952
2,229 Added 14.38%
17,732 $1.62 Million
Q1 2022

May 13, 2022

BUY
$73.51 - $82.4 $49,986 - $56,032
680 Added 4.59%
15,503 $1.27 Million
Q4 2021

Feb 01, 2022

BUY
$72.28 - $90.54 $49,728 - $62,291
688 Added 4.87%
14,823 $1.14 Million
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $87,592 - $96,330
1,222 Added 9.46%
14,135 $1.06 Million
Q2 2021

Aug 10, 2021

BUY
$70.31 - $77.77 $75,794 - $83,836
1,078 Added 9.11%
12,913 $1 Million
Q1 2021

Apr 30, 2021

SELL
$68.86 - $81.11 $30,573 - $36,012
-444 Reduced 3.62%
11,835 $912,000
Q4 2020

Jan 25, 2021

SELL
$71.77 - $79.65 $68,540 - $76,065
-955 Reduced 7.22%
12,279 $1 Million
Q3 2020

Nov 12, 2020

BUY
$73.18 - $82.95 $100,695 - $114,139
1,376 Added 11.6%
13,234 $1.1 Million
Q2 2020

Aug 13, 2020

SELL
$70.42 - $80.13 $5,985 - $6,811
-85 Reduced 0.71%
11,858 $917,000
Q1 2020

Apr 21, 2020

BUY
$63.36 - $87.82 $418,809 - $580,490
6,610 Added 123.95%
11,943 $919,000
Q4 2019

Feb 12, 2020

BUY
$77.58 - $87.54 $413,734 - $466,850
5,333 New
5,333 $485,000
Q3 2019

Nov 12, 2019

SELL
$76.08 - $82.93 $174,223 - $189,909
-2,290 Closed
0 $0
Q2 2019

Aug 15, 2019

BUY
$69.84 - $81.59 $146,873 - $171,583
2,103 Added 1124.6%
2,290 $192,000
Q1 2019

Jul 01, 2019

SELL
$69.58 - $79.36 $143,473 - $163,640
-2,062 Reduced 91.69%
187 $2.25 Million
Q1 2019

May 13, 2019

BUY
$69.58 - $79.36 $145,770 - $166,259
2,095 Added 1360.39%
2,249 $187,000
Q4 2018

Feb 12, 2019

BUY
$65.24 - $75.71 $9,916 - $11,507
152 Added 7600.0%
154 $2,000
Q3 2018

Nov 05, 2018

SELL
$57.69 - $67.84 $682,472 - $802,547
-11,830 Reduced 99.98%
2 $145,000
Q2 2018

Aug 15, 2018

BUY
$50.83 - $59.72 $601,420 - $706,607
11,832 New
11,832 $718,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Centaurus Financial, Inc. Portfolio

Follow Centaurus Financial, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Centaurus Financial, Inc. with notifications on news.